BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verougstraete N, Berth M, Vaneechoutte M, Delanghe J, Callewaert N. Interference of anti-streptavidin antibodies in immunoassays: a very rare phenomenon or a more common finding? Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:1673-80. [DOI: 10.1515/cclm-2019-1064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Wauthier L, Plebani M, Favresse J. Interferences in immunoassays: review and practical algorithm. Clin Chem Lab Med 2022. [PMID: 35304841 DOI: 10.1515/cclm-2021-1288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Nelson HA, La'ulu SL, Lu J, Doyle K. Mitigation of Biotin Interference in Manual and Automated Immunoassays by Preconjugating Biotinylated Antibodies to the Streptavidin Surface as an Alternative to Biotin Depletion. J Appl Lab Med 2022:jfab169. [PMID: 35018420 DOI: 10.1093/jalm/jfab169] [Reference Citation Analysis]
3 Ghazal K, Brabant S, Prie D, Piketty ML. Hormone Immunoassay Interference: A 2021 Update. Ann Lab Med 2022;42:3-23. [PMID: 34374345 DOI: 10.3343/alm.2022.42.1.3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
4 Ishikawa T, Sakai H, Itaya T, Hirotsugu S, Shikuma J, Miwa T, Suzuki R, Odawara M. Falsely diagnosed thyrotoxicosis caused by anti-streptavidin antibodies and pre-wash procedures. Thyroid Res 2021;14:17. [PMID: 34246285 DOI: 10.1186/s13044-021-00108-y] [Reference Citation Analysis]
5 Dahll LK, Haave EM, Dahl SR, Aas FE, Thorsby PM. Endogenous anti-streptavidin antibodies causing erroneous laboratory results more common than anticipated. Scandinavian Journal of Clinical and Laboratory Investigation 2021;81:92-103. [DOI: 10.1080/00365513.2020.1858493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]